Literature DB >> 4898866

Is there a place for proteinase inhibition? A review of the literature.

G D Lister.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4898866      PMCID: PMC2466889          DOI: 10.1136/pgmj.45.526.571

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  29 in total

Review 1.  FIBRINOLYSIS AND FORMATION OF BIOLOGICALLY ACTIVE POLYPEPTIDES.

Authors:  V EISEN
Journal:  Br Med Bull       Date:  1964-09       Impact factor: 4.291

Review 2.  PATHOLOGICAL FIBRINOLYSIS.

Authors:  A A SHARP
Journal:  Br Med Bull       Date:  1964-09       Impact factor: 4.291

3.  EXPERIMENTAL PANCREATITIS: USE OF A NEW ANTIPROTEOLYTIC SUBSTANCE, TRASYLOL.

Authors:  A D MCCUTCHEON
Journal:  Ann Surg       Date:  1963-08       Impact factor: 12.969

4.  QUANTITATION AND IDENTIFICATION OF VASOACTIVE SUBSTANCES LIBERATED DURING VARIOUS TYPES OF EXPERIMENTAL AND CLINICAL INTESTINAL ISCHEMIA.

Authors:  E E KOBOLD; A P THAL
Journal:  Surg Gynecol Obstet       Date:  1963-09

5.  EFFECT OF A TRYPSIN-INHIBITOR ON EXPERIMENTALLY INDUCED PANCREATITIS IN THE DOG.

Authors:  R B SMITH; R C ORAHOOD; S L WANGENSTEEN; G J BERAKHA; A ZAMELIS
Journal:  Surgery       Date:  1963-12       Impact factor: 3.982

6.  CHEMICAL MEDIATORS IN CLINICAL SEPTIC SHOCK.

Authors:  E E KOBOLD; R LUCAS; A P THAL
Journal:  Surg Forum       Date:  1963

7.  The release of vasoactive substances in acute pancreatitis.

Authors:  A P THAL; E E KOBOLD; M J HOLLENBERG
Journal:  Am J Surg       Date:  1963-06       Impact factor: 2.565

8.  Mechanisms of the hemodynamic effects of endotoxin.

Authors:  R P GILBERT
Journal:  Physiol Rev       Date:  1960-04       Impact factor: 37.312

9.  Inhibition of fibrinolytic and thromboplastic activity by Trasylol.

Authors:  C J Amris
Journal:  Scand J Haematol       Date:  1966

10.  In vitro and in vivo studies with trasylol, an anticoagulant and a fibrinolytic inhibitor.

Authors:  A H Dubber; G P McNicol; D Uttley; A S Douglas
Journal:  Br J Haematol       Date:  1968-01       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.